Antimicrobial Resistance

Preconference Seminar

The pre-conference meeting is a collaboration by the ECS, the national CF Patient Associations (France, Germany, Italy, Belgium, Netherlands, UK)
​​​​​​​and CFE. 


Jane Davies  (UK)
Pavel Drevinek (CZ)

Wednesday 30 March 2022

13:30 - 17:00


There is no additional registration fee for attendance at this Seminar, however, a special registration is required as attendance is limited to 50 participants.
Should you wish to attend the Seminar please add a note about your participation in this Seminar in the ‘Additional Comments’ section of the Basic Science conference registration


Part 1: The phenomenon of antimicrobial resistance in cystic fibrosis

  • AMR, epidemiology, current strategy of antibiotic therapy in CF - Pavel Drevinek (CZ)
  • How to determine and interpret antimicrobial susceptibility of CF pathogens - Rafael Canton (ES)
  • AMR and P. aeruginosa: towards the MDR phenotype - Helle Krogh Johansen (DK)
  • Does the CF resistome matter? - Lucas Hoffman (US)

Part 2: Novel antimicrobial approaches to fight CF infections

  • Does the CF resistome matter? - Clinical view - Lucas Hoffman (US)
  • Preclinical development of new anti-biofilm therapies - Tom Coenye (BE)
  • Phage therapy: The Belgian experience - Sarah Djebara (BE)
  • What is in the clinical pipeline - Pierre-Régis Burgel (FR)
  • General discussion and wrap-up - Jane Davies (UK)